Works in Journal of Experimental & Clinical Cancer Research (17569966), 2020, Vol 39, Issue 1


Results: 285
    1
    2
    3
    4
    5

    Aspartate β-hydroxylase as a target for cancer therapy.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. N.PAG, doi. 10.1186/s13046-020-01669-w
    By:
    • Kanwal, Madiha;
    • Smahel, Michal;
    • Olsen, Mark;
    • Smahelova, Jana;
    • Tachezy, Ruth
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01667-y
    By:
    • Lappano, Rosamaria;
    • Talia, Marianna;
    • Cirillo, Francesca;
    • Rigiracciolo, Damiano Cosimo;
    • Scordamaglia, Domenica;
    • Guzzi, Rita;
    • Miglietta, Anna Maria;
    • De Francesco, Ernestina Marianna;
    • Belfiore, Antonino;
    • Sims, Andrew H.;
    • Maggiolini, Marcello
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01632-9
    By:
    • Wang, Xiaojuan;
    • Wu, Fan;
    • Wang, Han;
    • Duan, Xiaoyuan;
    • Huang, Rong;
    • Tuersuntuoheti, Amannisa;
    • Su, Luying;
    • Yan, Shida;
    • Zhao, Yuechao;
    • Lu, Yan;
    • Li, Kai;
    • Yao, Jinjie;
    • Luo, Zhiwen;
    • Guo, Lei;
    • Liu, Jianmei;
    • Chen, Xiao;
    • Lu, Yalan;
    • Hu, Hanjie;
    • Li, Xingchen;
    • Bao, Mandula
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01628-5
    By:
    • Garufi, Alessia;
    • Baldari, Silvia;
    • Pettinari, Riccardo;
    • Gilardini Montani, Maria Saveria;
    • D'Orazi, Valerio;
    • Pistritto, Giuseppa;
    • Crispini, Alessandra;
    • Giorno, Eugenia;
    • Toietta, Gabriele;
    • Marchetti, Fabio;
    • Cirone, Mara;
    • D'Orazi, Gabriella
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50